BIOCANCELL THERAPEUTICS INC. Operating Cash Flow
BIOCANCELL THERAPEUTICS INC. reported Operating Cash Flow of -$1.53 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2012-05-10
- BIOCANCELL THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2012-03-31 was -$1.53M.
- BIOCANCELL THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2011-12-31 was -$1.36M.
- BIOCANCELL THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2011-09-30 was -$1.95M.
- BIOCANCELL THERAPEUTICS INC. net cash provided by (used in) operating activities for the quarter ending 2011-06-30 was -$1.20M.
- BIOCANCELL THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2011 was -$5.10M.
- BIOCANCELL THERAPEUTICS INC. net cash provided by (used in) operating activities for fiscal 2010 was -$3.05M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 81 month | Net Cash Provided by (Used in) Operating Activities 84 month | Net Cash Provided by (Used in) Operating Activities 87 month | Net Cash Provided by (Used in) Operating Activities 90 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | -$1.53M 10-Q · filed 2012-05-10 | -$2.89M derived: sum of 2 quarters · filed 2012-05-10 | -$4.84M derived: sum of 3 quarters · filed 2012-05-10 | -$6.04M derived: sum of 4 quarters · filed 2012-05-10 | -$24.69M 10-Q · filed 2012-05-10 | |||
| 2011-12-31 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$3.31M derived: sum of 2 quarters · filed 2012-03-30 | -$4.51M derived: sum of 3 quarters · filed 2012-03-30 | -$5.10M 10-K · filed 2012-03-30 | -$23.16M 10-K · filed 2012-03-30 | |||
| 2011-09-30 | -$1.95M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | -$3.15M derived: sum of 2 quarters · filed 2011-11-07 | -$3.74M 10-Q · filed 2011-11-07 | -$4.54M derived: sum of 4 quarters · filed 2012-05-10 | -$21.80M 10-Q · filed 2011-11-07 | |||
| 2011-06-30 | -$1.20M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-08-30 | -$1.79M 10-Q/A · filed 2011-08-30 | -$2.59M derived: sum of 3 quarters · filed 2012-05-10 | -$3.07M derived: sum of 4 quarters · filed 2012-05-10 | -$19.85M 10-Q/A · filed 2011-08-30 | |||
| 2011-03-31 | -$590.00K 10-Q · filed 2012-05-10 | -$1.40M derived: sum of 2 quarters · filed 2012-05-10 | -$1.87M derived: sum of 3 quarters · filed 2012-05-10 | |||||
| 2010-12-31 | -$807.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$1.28M derived: sum of 2 quarters · filed 2012-03-30 | -$3.05M 10-K · filed 2012-03-30 | |||||
| 2010-09-30 | -$473.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | -$2.24M 10-Q · filed 2011-11-07 | ||||||
| 2010-06-30 | -$1.77M 10-Q/A · filed 2011-08-30 |